S
Seung-Mo Hong
Researcher at University of Ulsan
Publications - 383
Citations - 21628
Seung-Mo Hong is an academic researcher from University of Ulsan. The author has contributed to research in topics: Pancreatic cancer & Cancer. The author has an hindex of 53, co-authored 361 publications receiving 17907 citations. Previous affiliations of Seung-Mo Hong include University of Virginia Health System & Johns Hopkins University School of Medicine.
Papers
More filters
Journal ArticleDOI
Human Neuralized is a novel tumour suppressor targeting Wnt/β-catenin signalling in colon cancer.
Joo Mi Yi,Taewook Kang,Yu Kyeong Han,Ha Young Park,Ju Hwan Yang,Jin-Han Bae,Jung-Soo Suh,Tae-Jin Kim,Joong-Gook Kim,Yan Hong Cui,Hiromu Suzuki,Kohei Kumegawa,Sung Joo Kim,Yi Zhao,In Ja Park,Seung-Mo Hong,Joon-Yong Chung,Su-Jae Lee +17 more
TL;DR: In this article , the authors considered NEURL to be a bona fide tumour suppressor in colorectal cancer and demonstrated that this tumour suppressive function depends on NEURL-mediated oncogenic β-catenin degradation.
Journal ArticleDOI
Pedunculated mucinous cystic neoplasm of the liver.
TL;DR: In this article, a 32-year-old woman was referred to the institution with a diagnosis of biliary cystic neoplasm and the mass was resected with partial hepatectomy.
Journal ArticleDOI
Pancreatic Lymphoma Masquerading as Autoimmune Pancreatitis
Jinoh Park,Dongwook Oh,Minseon Cheong,Jiyoon Kim,Jin Sun Oh,Tae Jun Song,Seung-Mo Hong,Myung-Hwan Kim +7 more
TL;DR: A case of pancreatic lymphoma masquerading as AIP with literature review is presented, with a 61-years-old man presented with acute pancreatitis who is currently undergoing chemotherapy.
Journal ArticleDOI
Synergistic therapeutic combination with a CAF inhibitor enhances CAR-NK-mediated cytotoxicity via reduction of CAF-released IL-6
Young Eun Lee,Gabriella Go,Eunee Koh,Han Na Yoon,Minkoo Seo,Seung-Mo Hong,Jisu Jeong,Jin-Chul Kim,Duck Cho,Tae Sung Kim,Song Cheol Kim,Eunsung Jun,Mihue Jang +12 more
TL;DR: In this article , an antifibrotic drug, nintedanib, was selected for synergistic therapeutic combination to overcome CAF-induced NK dysfunction, which resulted in intense NK infiltration in vivo.